Imagine a world where nearly every cancer patient was diagnosed early, at a treatable stage, had access to targeted therapies and their prognosis was vastly improved. Understanding the deep heterogeneity within tumours may help us get closer to delivering this vision.
Current precision oncology approaches are already impacting patient care, but they remain underused. Targeted therapies do not exist for all tumour types, diagnostic tests are not yet widely implemented in healthcare and there is a wealth of data to sift through in order to find actionable insights. How can we move closer to fulfilling the vision of precision oncology?
Precision Oncology ONLINE is a 3-part webinar series that will bring together global experts to discuss how we can leverage our current knowledge, expand on it and deliver the very best treatment options to patients.
This webinar series will:
By registering for the first webinar in the series you will automatically gain access to the subsequent webinars. Register for the webinar series here.
One third of couples have fertility problems, which are often due to male factors, including nonobstructive azoospermia. Men with nonobstructive azoospermia have intact seminal ducts but impaired spermatogenesis. A growing number of gene variants have been implicated. New research findings are summarized in a short video.